利用病毒RNA处理的阿基里斯跟脚,开发新型抗病毒药物
Ali Zahedi Amiri1, Choudhary Ahmed1, Subha Dahal2
1Virocarb Inc., Toronto, ON M8V 3Y3, Canada.
Viruses
|January 25, 2025
概括
一个新的小分子,5342191,通过向宿主细胞RNA过程,有效地抑制多种病毒感染. 这种广泛的抗病毒方法显示出对抗冠状病毒和流感等病毒的前景,目前还没有观察到抗药性.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 有限的抗病毒选择和快速的病毒耐药性需要新的治疗策略.
- 准宿主细胞RNA代谢提供了传统抗病毒开发的替代方案.
- 小分子5342191之前被确定为HIV-1复制的抑制剂.
研究的目的:
- 为了研究小分子5342191.1的广泛抗病毒潜力.
- 描述5342191对各种病毒感染的作用机制.
- 评估对5342191.1产生抗药性发展的可能性.
主要方法:
- 在细胞培养中测试5342191对腺病毒,冠状病毒和流感的疗效.
- 分析病毒RNA积累和病毒结构蛋白的表达.
- 研究参与5342191抗病毒活性的细胞信号通路.
主要成果:
- 5342191强烈抑制了腺病毒,冠状病毒和流感的复制.
- 抑制与改变病毒RNA积累和减少病毒蛋白质表达有关.
- 与蛋白酶/聚合酶抑制剂不同,没有孤立的冠状病毒或流感的耐药变体.
结论:
- 5342191通过调节宿主细胞RNA代谢来表现出广泛的抗病毒活性.
- 该化合物激活细胞信号通路,包括GPCR和MAPK,影响SR激酶.
- 准细胞过程为开发弹性,广泛的抗病毒疗法提供了一个有希望的途径.
相关概念视频
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K


